FDA clears hyperplasia treatment from Pulse Biosciences
Pulse Biosciences announced today that the FDA granted 510(k) clearance for its CellFx system with expanded indication.
Stay updated with breaking news from Pulse Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pulse Biosciences announced today that the FDA granted 510(k) clearance for its CellFx system with expanded indication.
Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results HAYWARD, Calif. [Business Wire] - March 31, 2022 -... | March 31, 2022
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Pulse Biosciences, Inc. (NASDAQ: PLSE) securities between January...
Earlier this week a class action complaint was filed against the defendants Pulse Biosciences, Inc.by the plaintiff Viron Bryan Ngosiok in the Northern
/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Pulse Biosciences, Inc. (NASDAQ: PLSE) securities between January...